The ASAM Joint Clinical Practice Guideline on Benzodiazepine Tapering is now available. Some of us at BIC, including the late Dr. Christy Huff, served voluntarily on the Patients with Lived Experience (PWLE) panel (see our names on page…
In 2017, Benzodiazepine Information Coalition (BIC) led a community-wide reporting drive through MedWatch, the FDA’s adverse event reporting program, which, in part, resulted in the 2020 FDA boxed warning on benzodiazepines. To read more about…
We received a new FDA communication dated August 3, 2022 about benzodiazepine use during pregnancy: This communication is to inform you that FDA is requiring manufacturers of all benzodiazepine medicines to update and standardize the…
Duke University’s Margolis Center for Health Policy, in cooperation with the FDA, held a public workshop Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives on July 12 and 13. Our director, Dr. Christy Huff,…
In 2017 we started our MedWatch Reporting Program. This ongoing program gives patients information to report their own benzodiazepine experiences to the FDA. So far it has been a success. In September, 2020, the FDA…
An excerpt from Dark Side of Sleeping Pills Chapter 8A. A free copy of the full book is available here. When we reported that people who took sleeping pills died 4.6 times faster and suffered…
While the US and the world is convulsed by COVID-19, a dramatic admission has been made by the US Food and Drugs Administration about dangerous benzodiazepine drugs, acknowledging patients have suffered severe withdrawal side effects…
In 2017, Benzodiazepine Information Coalition initiated a campaign reporting patient harm to the FDA through their MedWatch Adverse Event Reporting System. Many of the Facebook groups and BenzoBuddies joined in. We shared our message far and wide,…
